Early Menopause & POI Blood Test UK: Which Tests Are Used, What They Mean, and What Comes Next

1. Early menopause vs POI: the difference

The two terms are related but not identical, and the line between them is age.

• Early menopauserefers to menopause that happens between 40 and 45 — earlier than average, but within a recognised window.
• Premature ovarian insufficiency (POI)refers to the ovaries reducing their normal function before the age of 40. It is sometimes called premature ovarian failure, though “insufficiency” is the preferred term because ovarian activity can fluctuate rather than stop cleanly.

POI affects roughly 1 in 100 women under 40. It is more common than many people assume, and it is frequently missed for years because the symptoms are attributed to stress, thyroid problems, or simply not expected at a younger age.

2. Why testing matters under 45

For women over 45, NICE guideline NG23 advises diagnosing the menopause on symptoms alone. Under 45, that advice flips: NICE recommends considering FSH to help diagnose menopause in women aged 40 to 45 with symptoms, and using FSH to diagnose POI in women under 40.

There are two reasons the test earns its place here. First, the diagnosis is less obvious: younger women and their clinicians do not always expect menopause, so a result helps make the invisible visible. Second, the stakes are higher. An earlier loss of oestrogen has long-term implications for bone density and cardiovascular health, which is why confirming what is happening, and acting on it, matters more than it would at 52.

That is the opposite of the usual “you do not need a test” message — and it is worth knowing, because younger women are sometimes told their symptoms cannot be menopause precisely because of their age.

3. The main test: FSH, taken twice

Follicle-stimulating hormone (FSH) rises as the ovaries become less responsive, so a high FSH is the central signal of menopause and POI. Because hormones fluctuate, a single raised reading is not enough on its own.

For POI in particular, the standard is two FSH measurements in the menopausal range, taken 4 to 6 weeks apart, in a woman with relevant symptoms or absent periods. A persistently raised FSH alongside a low oestradiol supports the picture; a one-off high reading on a single day does not.

This is also why a normal FSH does not rule early menopause out on a single test. In the earlier stages, FSH can swing between raised and normal from one cycle to the next, which is exactly why repeat testing and symptoms are read together.

4. The markers that rule out mimics

A large part of testing under 45 is making sure something else is not being mistaken for menopause. Several conditions produce overlapping symptoms or stop periods, and they are managed completely differently.

Any result outside its range belongs in a conversation with a GP or specialist, who can read it in the context of everything else.

5. Where AMH fits

Anti-Müllerian hormone (AMH) reflects the remaining pool of eggs in the ovaries and falls as that pool shrinks. A very low AMH is consistent with reduced ovarian reserve, and it can add useful context, particularly where fertility is part of the picture.

AMH is not the test that confirms menopause or POI on its own — FSH and oestradiol with symptoms do that — but it is often measured alongside them, and it is especially relevant for anyone weighing up fertility decisions. The fertility blood test guide goes into AMH in more depth.

6. What a diagnosis changes

A diagnosis of early menopause or POI is not only a label for current symptoms. Because oestrogen has a protective role in bone and cardiovascular health, an earlier decline is generally managed actively rather than left to run.

In practice, guidance from NICE and the British Menopause Society supports offering hormone treatment to women with POI, in the absence of a reason not to, at least until the average age of natural menopause — both to manage symptoms and to support long-term bone and heart health. The specifics are a decision for a clinician with you, taking your history into account.

For what that monitoring looks like once treatment starts, the HRT blood test guide covers the practical side.

7. NHS and private testing

Under 45, this is firmly something to take to your GP. Early menopause and POI are diagnoses with real consequences, and they deserve proper clinical follow-up, including the repeat FSH test, the conditions that need ruling out, and a discussion about treatment and bone health.

Private testing can still help — for a faster baseline, to bring clear numbers to an appointment, or when you have struggled to be heard and want the hormone picture in hand. A comprehensive panel covering FSH, LH, oestradiol, AMH and thyroid gives a clinician more to work with than a single hormone in isolation. It complements an NHS pathway here; it does not replace it.

8. When to take the blood

If you are still having periods, even irregular ones, test on day 2 to 5 of your cycle, counting day 1 as the first day of full bleeding, for the most reliable FSH and oestradiol. If your periods have stopped, you can test on any day.

For POI, remember that the diagnosis relies on two FSH samples 4 to 6 weeks apart, so plan for a repeat rather than expecting a single test to settle it. Morning testing is preferred, and fasting if your panel also includes metabolic markers.

9. Frequently asked questions